MK8266
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK8266, covering 2019-08-12 to 2019-08-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002) [Phase 1]